SENS PubMed Publication Search
Revisiting sensitivity of senescent cells to BH3 mimetics
Trends Pharmacol Sci. 2024 Jan 19:S0165-6147(24)00002-6. doi: 10.1016/j.tips.2024.01.002.
Nadine Martin 1, Anda Huna 2, Athanasios Tsalikis 2, David Bernard 3
Abstract:
B cell leukemia/lymphoma 2 (BCL2) homology domain 3 (BH3) mimetics were reported to selectively kill senescent cells and improve age-related diseases. Defining why these cells show increased sensitivity to these molecules will help to identify new pharmacological compounds with senolytic activity. Here, we discuss how recent research findings provide new clues to understand this vulnerability.
PMID: 38245492
Tags: BCL2, BH3, senolytics